Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

06. Août 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1972


	Articles 1 - 20 / 39427

	Reply to: Comments on "Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition (EPIC)Â Study". Int J Cancer Bonet C, Agudo A, Jakszyn P. PMID: 42559710 [PubMed - as supplied by publisher]
	Transthoracic versus Transhiatal Esophagectomy for Esophageal Squamous Cell Carcinoma. JSLS Gunes A, Akay O, Ozdamar M, Guler M, Yazicioglu MB, Yuksel A, Tiryaki C. PMID: 42559527 [PubMed - indexed for MEDLINE]
	Predictive performance of the Modified Frailty Index and ASA-PS classification for 30-day mortality after esophagectomy in patients with esophageal cancer. Front Oncol Chaochankit W, Sunpaweravong S, Sungworawongpana C. PMID: 42558418 [PubMed]
	Comments on "Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition (EPIC) Study". Int J Cancer Sun M, Zang D, Chen J. PMID: 42557996 [PubMed - as supplied by publisher]
	Is Pyloroplasty Necessary During Esophagectomy? Review of Literature and Technical Considerations. Adv Surg Christie IG, Alicuben ET, Pennathur A, Luketich S, Luketich JD. PMID: 42556952 [PubMed - indexed for MEDLINE]
	CT-derived myosteatosis as a predictor of postoperative outcomes in esophagogastric cancer surgery: a systematic review. Front Med (Lausanne) Rondovic G, Sarac M, Lekovic I, Maric N, Sarac S, Stamenkovic D, Stojanovic M, Bojic S. PMID: 42553334 [PubMed]
	Prognostic analysis of first-recurrence/metastasis esophageal squamous cell carcinoma: chemoimmunotherapy combined with radiotherapy as one of the optimal clinical management strategies. Front Immunol Li Y, Li Q, Wang K, Gao M, Tian L, Liu M, Bu Y, Cui Y. PMID: 42553314 [PubMed - indexed for MEDLINE]
	Medical information and decision-making in palliative cancer: a qualitative study of patients' perceptions, needs, and preferences regarding physician communication. BMC Palliat Care Roick J, Heise C, Lambrecht N, Michl P, Porzelle J, Rauschenberg S, Reinacher-Schick A, Rosenau H, Schildmann J, Schneider T, Schulmann K, Sommerlatte S, Richter M. PMID: 42552529 [PubMed - indexed for MEDLINE]
	Social genomics and cancer - untangling nature from nurture in squamous cell carcinoma outcomes. Front Oncol Rahimabad PK, Shaban-Nejad A, Davis R, Hayes DN, Makowski L, Schwartz DL. PMID: 42548724 [PubMed]
	Bridging the gap: modern pharyngolaryngoesophagectomy techniques and the rise of neoadjuvant/immunotherapy approaches. World J Surg Oncol Nteka F, Triantafyllou T, Rouvelas I, Gkoutziotis I, Sakarellos P, Tolia M, Karavokyros I, Mpallas K, Schizas D. PMID: 42547869 [PubMed - indexed for MEDLINE]
	Winning the battle against Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med Katzka DA. PMID: 42547280 [PubMed - indexed for MEDLINE]
	Development of an Esophageal Cancer-specific Nutrition Impact Symptom Scale for Individualized Postoperative Nutritional Nursing. J Vis Exp Cai S, Fu W. PMID: 42545907 [PubMed - indexed for MEDLINE]
	A single-arm phase III trial evaluating the non-inferiority of less-intensive surveillance for early gastric cancer: JCOG2504 (less-surveillance EGC). Jpn J Clin Oncol Kawabata K, Hayashi T, Makuuchi R, Yamada T, Yokoyama M, Uozumi T, Mitome N, Fukuda H, Kurokawa Y, Boku N, Yoshikawa T. PMID: 42545799 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Neoadjuvant Chemoimmunotherapy Versus Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis. Ann Surg Oncol Xu Y, Liang Y, Gao W, Yang X, Qin F, Tao Z, Li X, Chen K, Liang Y. PMID: 42545420 [PubMed - as supplied by publisher]
	Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes. Dis Esophagus Nomura M, Bronzwaer SFC, Kroese TE, van Rossum PSN, Ruurda JP, van Hillegersberg R, Kato K, Ogata T, Kanda M, Hamai Y, Tsubosa Y, Yoshii T, Furuta M, Sakanaka K, Matsuda S, Tsushima T, Laarhoven HWM, Takeuchi H. PMID: 42544486 [PubMed - indexed for MEDLINE]
	Tumor-microenvironment-mediated immune escape drives trastuzumab resistance in HER2-positive gastric cancer. Gastroenterol Rep (Oxf) Lv H, Zhao W, Wang SQ, He Y, Nie C, Chen XB. PMID: 42542713 [PubMed]
	Correction: Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma. BMC Cancer Mao Y, Gao Z, Sun Y, Shao C, Duan H, Yan X. PMID: 42542548 [PubMed - in process]
	Associations of PD-L1 expression status, tumor histology and patient ethnic background with immunotherapy outcomes in patients with advanced esophageal cancer. Front Pharmacol Cai X, Xie J, Zhao B. PMID: 42539557 [PubMed]
	Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study. Head Neck Kano S, Kawakita D, Honma Y, Takahashi H, Hanazawa T, Tsukahara K, Fujii S, Okami K, Yamazaki K, Ueki Y, Saito Y, Ozawa H, Imaizumi S, Arai T, Iwaki S, Hanyu K, Yamauchi M, Tanaka R, Yamamura K, Sekimizu M, Fushimi C, Matsuki T, Utsumi Y, Nakaguro M, Nagao T, Tada Y, Multi. PMID: 42538489 [PubMed - as supplied by publisher]
	A phase II randomized trial comparing radiation doses in concurrent chemoradiotherapy with TS-1/nedaplatin for curative treatment of newly diagnosed or recurrent esophageal cancer. Int J Radiat Oncol Biol Phys Yamashita H, Sawayanagi S, Kono M, Kiritoshi T, Morishima K, Jinnouchi H, Nozawa Y, Katano A. PMID: 42537853 [PubMed - as supplied by publisher]

Articles 1 - 20 / 39427

Page 1 de 1972



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité